Daré Bioscience Explores “DARE to PLAY” Sildenafil Cream As Novel Women’s Sexual Arousal Treatment

Daré Bioscience, Inc. (NASDAQ: DARE) recently detailed its investigational topical product, DARE to PLAY™ Sildenafil Cream, developed specifically for women experiencing genital arousal concerns. In the company’s November 17, 2025 presentation, its leadership and clinical collaborators highlighted the unmet need in female sexual health, noting that existing pharmacologic treatment options remain very limited. The cream uses the active ingredient Sildenafil Citrate — the same PDE‑5 inhibitor found in the oral treatment for male erectile dysfunction — but reformulated topically for local application to vulvar‑vaginal tissue. The idea: to directly enhance genital blood flow and arousal response while avoiding systemic effects associated with oral delivery. According to Daré, early clinical data show that DARE to PLAY increased measurable blood flow to genital tissue and improved arousal sensation — effects were observed within 10–15 minutes of application in thermography and blood‑flow studies. Crucially, the company emphasised that the product is designed to be the first commercially available evidence‑based sildenafil cream for women’s sexual arousal disorder (FSAD or arousal‑related dysfunction). It intends to launch via a Section 503B outsourcing facility (in the U.S.) before the end of 2025, subject to regulatory pathway execution. While promising, the company also noted that the candidate remains investigational and has not yet been approved by the U.S. Food and Drug Administration. Ongoing regulatory discussions, additional clinical data, and manufacturing readiness remain pivotal. In summary, Daré aims to address a historically under‑served area in women’s sexual health by leveraging a topical sildenafil formulation that may offer a new treatment option for genital arousal concerns — the coming months will be key as they work toward commercialisation. #WomenHealthInnovation #FemaleSexualArousalDisorder #TopicalSildenafil #DareBioscience #SlimScan #GrowthStocks #CANSLIM